Greenleaf Envi. (GREENLEAF)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 46.45% suggests efficient use of capital, a rare quality in small-cap waste management.
• P/E of 11.14 is modest; latest quarter net profit of ₹3 Cr on sales of ₹21 Cr implies a healthy ~14% margin.
• Promoter holding of 56.37% aligns management with minority shareholders.
• Waste management is an essential, recurring-demand industry.

Concerns

• Sales and profit growth are both 0.00%, so there is no visible growth engine.
• Piotroski F-score of 3/9 is weak and flags possible financial stress or deteriorating fundamentals.
• No dividend yield means investors get no income while waiting for a recovery.
• Lack of ROE, book value, and debt-equity data makes a proper Graham-style margin-of-safety check impossible.

AI Analysis

At ₹70, Greenleaf Envi wears a cheap multiple—P/E of 11.14 on a market cap of just ₹70 crore. But cheap can be a value trap if quality is missing. The return on capital employed is striking at 46.45%; that tells me the business earns well on the capital it deploys, a quality I admire. The latest quarter also shows sales of ₹21 crore and net profit of ₹3 crore, a margin of roughly 14%. Promoters hold 56.37%, so interests are aligned. Yet I must be honest: the scorecard is incomplete. There is no ROE, book value, or debt-to-equity data, and the Piotroski F-score is just 3 out of 9, which rings alarm bells about financial health. Sales and profit growth are both zero; there is no dividend to compensate while I wait. The 52-week range of ₹52.50 to ₹125.20 shows the stock has lost nearly half its value from the high—sometimes Mr. Market offers bargains, but sometimes he is telling you something. A zero-growth business at 11 times earnings is not obviously cheap if capital returns are deteriorating; the high ROCE needs auditing, not cheerleading. I would need evidence that flat profit is temporary, that receivables and operating cash flows are sound, and that the F-score is recovering. If Greenleaf can convert its impressive ROCE into steady growth and cash dividend, this could be a decent small-cap. Until then, I watch, I do not jump.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer